Baird Financial Group, Inc. - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 262 filers reported holding EDITAS MEDICINE INC in Q3 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$202,527
-2.7%
25,965
+2.7%
0.00%0.0%
Q2 2023$208,046
+14.5%
25,279
+0.9%
0.00%
Q1 2023$181,692
+119434.2%
25,061
+46.1%
0.00%
Q4 2022$152
-99.9%
17,157
+57.8%
0.00%
Q3 2022$133,000
+6.4%
10,872
+3.6%
0.00%
Q2 2022$125,000
-39.0%
10,498
-2.5%
0.00%
-100.0%
Q1 2022$205,000
-22.6%
10,763
+8.0%
0.00%0.0%
Q4 2021$265,0009,9630.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q3 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 1,674,435$51,455,00013.05%
TRV GP III, LLC 906,176$27,847,0009.75%
ARK Investment Management 1,112,845$34,198,0002.72%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,709,400$52,530,0002.07%
Casdin Capital, LLC 133,333$4,097,0001.00%
Global Thematic Partners, LLC 614,052$18,869,0000.62%
MORGENS WATERFALL VINTIADIS & CO INC 20,000$615,0000.48%
Ghost Tree Capital, LLC 65,000$1,997,0000.47%
ACUTA CAPITAL PARTNERS, LLC 64,000$1,967,0000.37%
VIKING GLOBAL INVESTORS LP 1,709,401$52,530,0000.32%
View complete list of EDITAS MEDICINE INC shareholders